SA
RPRX logo
Royalty Pharma plc(RPRX)
Updated 12:44 PM ETAbout this dataData status
$68.01▼-0.66 (-0.96%)

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 26.5 · elevated volatility

Overview →

Royalty Pharma plc (RPRX)

R&D Expenses

$251.80M

TTM · Period ending: · USD

RPRX logo

RPRX R&D Expenses

Latest reported$251.80M
RPRX R&D Expenses ($98.38M → $251.80M)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

RPRX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Royalty Pharma plc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
452,000,000
2,000,000
52,000,000
177,106,000
200,084,000
26,289,000
83,036,000
392,609,000
117,866,000
91,021,000
98,381,000

Frequently asked questions: RPRX r&d expenses

What is Royalty Pharma plc (RPRX)'s current r&d expenses?

Royalty Pharma plc (RPRX)'s latest reported r&d expenses (TTM) is $251.80M as of Sep 30, 2026. Research and development spending.

How much historical r&d expenses data is available for RPRX?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare RPRX's r&d expenses to peers or set an alert?

You can open RPRX's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.